These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 16364864

  • 1. Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction.
    Shitrit D, Ollech JE, Ollech A, Bakal I, Saute M, Sahar G, Kramer MR.
    J Heart Lung Transplant; 2005 Dec; 24(12):2148-52. PubMed ID: 16364864
    [Abstract] [Full Text] [Related]

  • 2. Tacrolimus dosage requirements in lung transplant recipients receiving antifungal prophylaxis with voriconazole followed by itraconazole: a preliminary prospective study.
    Enderby CY, Heckman MG, Thomas CS, Keller CA.
    Clin Transplant; 2014 Aug; 28(8):911-5. PubMed ID: 24931421
    [Abstract] [Full Text] [Related]

  • 3. Voriconazole and itraconazole in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction.
    Kramer MR, Amital A, Fuks L, Shitrit D.
    Clin Transplant; 2011 Aug; 25(2):E163-7. PubMed ID: 21158923
    [Abstract] [Full Text] [Related]

  • 4. Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506).
    Kramer MR, Merin G, Rudis E, Bar I, Nesher T, Bublil M, Milgalter E.
    Transplant Proc; 1997 Sep; 29(6):2657-9. PubMed ID: 9290780
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study.
    Biancofiore G, Bindi ML, Baldassarri R, Romanelli AM, Catalano G, Filipponi F, Vagelli A, Mosca F.
    Transpl Int; 2002 Jul; 15(7):341-7. PubMed ID: 12122510
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
    Lumlertgul D, Noppakun K, Rojanasthien N, Kanchanarattanakorn K, Jittikanont S, Manoyot A, Bunnachak D, Ophascharoensuk V.
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interaction between omeprazole and tacrolimus in renal allograft recipients: a clinical-analytical study.
    Pascual J, Marcén R, Orea OE, Navarro M, Alarcón MC, Ocaña J, Villafruela JJ, Burgos FJ, Ortuño J.
    Transplant Proc; 2005 Nov; 37(9):3752-3. PubMed ID: 16386527
    [Abstract] [Full Text] [Related]

  • 12. Coadministration of digoxin with itraconazole in renal transplant recipients.
    Mathis AS, Friedman GS.
    Am J Kidney Dis; 2001 Feb; 37(2):E18. PubMed ID: 11157404
    [Abstract] [Full Text] [Related]

  • 13. Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
    Alloway R, Steinberg S, Khalil K, Gourishankar S, Miller J, Norman D, Hariharan S, Pirsch J, Matas A, Zaltzman J, Wisemandle K, Fitzsimmons W, First MR.
    Transplant Proc; 2005 Mar; 37(2):867-70. PubMed ID: 15848559
    [Abstract] [Full Text] [Related]

  • 14. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Berge M, Guillemain R, Boussaud V, Pham MH, Chevalier P, Batisse A, Amrein C, Dannaoui E, Loriot MA, Lillo-Le Louet A, Billaud EM.
    Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study.
    Sharpe MD, Ghent C, Grant D, Horbay GL, McDougal J, David Colby W.
    Transplantation; 2003 Sep 27; 76(6):977-83. PubMed ID: 14508365
    [Abstract] [Full Text] [Related]

  • 16. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 17. Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis.
    Fan Y, Xiao YB, Weng YG.
    Transplant Proc; 2009 Jun 15; 41(5):1821-4. PubMed ID: 19545736
    [Abstract] [Full Text] [Related]

  • 18. First clinical experience with the new once-daily formulation of tacrolimus.
    First MR.
    Ther Drug Monit; 2008 Apr 15; 30(2):159-66. PubMed ID: 18367975
    [Abstract] [Full Text] [Related]

  • 19. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S, Hardinger KL, Crippin J, Korenblat K, Lisker-Melman M, Lowell JA, Chapman W.
    Liver Transpl; 2008 Feb 15; 14(2):173-80. PubMed ID: 18236391
    [Abstract] [Full Text] [Related]

  • 20. Clinical relevance and prevalence of polymorphisms in CYP3A5 and MDR1 genes that encode tacrolimus biotransformation enzymes in liver transplant recipients.
    Barrera-Pulido L, Aguilera-García I, Docobo-Pérez F, Alamo-Martínez JM, Pareja-Ciuró F, Nuñez-Roldán A, Gómez-Bravo MA, Bernardos-Rodríguez A.
    Transplant Proc; 2008 Nov 15; 40(9):2949-51. PubMed ID: 19010156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.